WDR5 was identified as a key epigenetic regulator in GSC organoids, and pharmacological WDR5 inhibition suppressed several stem cell marker genes and reduced self-renewal and tumor initiation [190], indicating that epigenetic regulatory scaffolds may provide feasible targets specifically in GSCs. This evidence concerns the gene WDR5 and neoplasm.